ARCHIVES

Congressional Committee, SEC Probe ImClone’s Statements To Shareholders.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

NCI-Funded Modelers Accurately Predicted Outcome Of Lung Cancer Screening Trial

November 26, 2010

John Mendelson Says M.D. Anderson Plans to Accelerate Role In Translational Research

May 7, 1999

NCI Advisors Approve Plan For Repository For Prostate Cancer Issue Specimens

March 19, 1999

Two Avastin Trials Show OS Benefit In Advanced Disease

August 27, 2010

DCBD Board Okays Recompetition Of Human Tissue Network

June 30, 1989

Appreciation: Quack-Buster Saul Green Used Science to Debunk Alternative Medicine Claims.

July 13, 2007